Novo Nordisk invests $60 mln to expand insulin plant in Kalundborg

* Danish pharmaceutical company Novo Nordisk is

investing 400 million Danish crowns ($59.70 million) in a 500

square meter extension of the world's largest insulin production

plant in Kalundborg, it said on Monday.

Read more